title: Mammalian mitogen-activated protein kinase pathways are regulated through formation of specific kinase-activator complexes.
abstract: Mammalian cells contain at least three signaling systems which are structurally related to the mitogen-activated protein kinase (MAPK) pathway. Growth factors acting through Ras primarily stimulate the Raf/MEK/MAPK cascade of protein kinases. In contrast, many stress-related signals such as heat shock, inflammatory cytokines, and hyperosmolarity induce the MEKK/SEK(MKK4)/SAPK(JNK) and/or the MKK3 or MKK6/p38(hog) pathways. Physiological agonists of these pathway types are either qualitatively or quantitatively distinct, suggesting few common proximal signaling elements, although past studies performed in vitro, or in cells using transient over-expression, reveal interaction between the components of all three pathways. These studies suggest a high degree of cross-talk apparently not seen in vivo. We have examined the possible molecular basis of the differing agonist profiles of these three MAPK pathways. We report preferential association between MAP kinases and their activators in eukaryotic cells. Furthermore, using the yeast 2-hybrid system, we show that association between these components can occur independent of additional eukaryotic proteins. We show that SAPK(JNK) or p38(hog) activation is specifically impaired by co-expression of cognate dominant negative MAP kinase kinase mutants, demonstrating functional specificity at this level. Further divergence and insulation of the stress pathways occurs proximal to the MAPK kinases since activation of the MAPK kinase kinase MEKK results in SAPK(JNK) activation but does not cause p38(hog) phosphorylation. Therefore, in intact cells, the three MAPK pathways may be independently regulated and their components show specificity in their interaction with cognate cascade members. The degree of intermolecular specificity suggests that mammalian MAPK signaling pathways may remain distinct without the need for specific scaffolding proteins to sequester components of individual pathways.
authors.affiliation: Department of Medicine and The Ontario Cancer Institute Princess Margaret Hospital, 610 University Ave., Toronto, Ontario, M5G 2M9 Canada.
authors.forename: B W
authors.initials: BW
authors.lastname: Zanke
authors.forename: E A
authors.initials: EA
authors.lastname: Rubie
authors.forename: E
authors.initials: E
authors.lastname: Winnett
authors.forename: J
authors.initials: J
authors.lastname: Chan
authors.forename: S
authors.initials: S
authors.lastname: Randall
authors.forename: M
authors.initials: M
authors.lastname: Parsons
authors.forename: K
authors.initials: K
authors.lastname: Boudreau
authors.forename: M
authors.initials: M
authors.lastname: McInnis
authors.forename: M
authors.initials: M
authors.lastname: Yan
authors.forename: D J
authors.initials: DJ
authors.lastname: Templeton
authors.forename: J R
authors.initials: JR
authors.lastname: Woodgett
mesh_terms: D000818:Animals; D019556:COS Cells; D002460:Cell Line; D004789:Enzyme Activation; D051379:Mice; D010766:Phosphorylation; D011233:Precipitin Tests; D011494:Protein Kinases / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction
chemical_list: D011494:Protein Kinases